Latest Articles

Publication Date
Ultrasound-based model finds endometrial malignancies - AuntMinnie

Ultrasound-based model finds endometrial malignancies AuntMinnie

Published: April 22, 2025, 5:51 p.m.
Endometriosis presenting as a rectal stricture in a patient with ulcerative colitis and primary sclerosing cholangitis: A case report - Frontiers

Endometriosis presenting as a rectal stricture in a patient with ulcerative colitis and primary sclerosing cholangitis: A case report Frontiers

Published: April 22, 2025, 9:22 a.m.
A Case Series: Activity of Pembro-Lenvatinib in dMMR EC Who Have Not Responded to Pembro-Mono - OncLive

A Case Series: Activity of Pembro-Lenvatinib in dMMR EC Who Have Not Responded to Pembro-Mono OncLive

Published: April 21, 2025, 1:17 p.m.
Conceiving With Endometriosis: What Strategies Can Increase Your Chances? - OnlyMyHealth

Conceiving With Endometriosis: What Strategies Can Increase Your Chances? OnlyMyHealth

Published: April 20, 2025, 7:24 p.m.
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - BioSpace

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 18, 2025, 5:25 a.m.
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - The Malaysian Reserve

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 18, 2025, 12:16 a.m.
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - Yahoo Finance

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 17, 2025, 5:15 p.m.
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - Newswire.ca

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 17, 2025, 5:15 p.m.
A deeply frustrating line-by-line reading of Casey Costello’s letter to Health NZ - The Spinoff

A deeply frustrating line-by-line reading of Casey Costello’s letter to Health NZ The Spinoff

Published: April 17, 2025, 9:02 a.m.
Aditxt Subsidiary Pearsanta Receives IRB Approval to Initiate Clinical Study of Blood-Based Diagnostic for Endometriosis with Patient Enrollment Planned to Begin in May 2025 - Quantisnow

Aditxt Subsidiary Pearsanta Receives IRB Approval to Initiate Clinical Study of Blood-Based Diagnostic for Endometriosis with Patient Enrollment Planned to Begin in May 2025 Quantisnow

Published: April 16, 2025, 12:15 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!